Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001085146-25-001780·NKGen Biotech, Inc.
Schedule 13G ownership disclosure
NKGEN BIOTECH INC
Common Stock, $0.0001 par value per share · CUSIP: 65488A101
Event date: 2024-10-17
- Filing-level shares
- 2,797,661
- Percent of class
- 7.91%
- PATHSTONE FAMILY OFFICE, LLC
Shares: 2,797,661 · Class: 7.91%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-001780
- Form type
- SCHEDULE 13G
- Filer
- NKGen Biotech, Inc.
- CIK
- CIK 1845459
- Filed
- Feb 28, 2025
- Reporting period
- Oct 17, 2024
- Description
- Schedule 13G beneficial ownership